PharmaEssentia’s BESREMi (ropeginterferon alfa-2b-njft) Now Recommended as a Preferred First-line Cytoreductive Therapy for Polycythemia Vera in Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
Update based on NCCN’s determination of superior efficacy, safety and evidence for BESREMi in high and low-risk patients, reflecting an...

West Indies Capitalise on Dhaka Dominance as Bangladesh Fight for Survival in Sylhet
Brown’s late block lifts 76ers past Pistons as LeBron makes 16,000 mark
Chinese tape maker Crown New Materials surges 787% in Shenzhen debut, creating paper billionaires
Ekadashi kab hai in 2026: Rama on Nov 5, Devutthana on Nov 20, Papankusha on Oct 22
Navy Court-Martials Captain, Lieutenant Commander Over INS Brahmaputra Capsizing 





























